NASDAQ:MOTS - Motus GI Stock Price, Forecast & News

Motus GI trades on the NASDAQ under the ticker symbol "MOTS."

Motus GI Holdings Inc (NASDAQ:MOTS) posted its earnings results on Thursday, November, 14th. The company reported ($0.18) EPS for the quarter, beating analysts' consensus estimates of ($0.25) by $0.07. View Motus GI's Earnings History.

Motus GI is scheduled to release their next quarterly earnings announcement on Wednesday, March 25th 2020. View Earnings Estimates for Motus GI.

2 analysts have issued twelve-month price objectives for Motus GI's stock. Their forecasts range from $6.00 to $10.00. On average, they expect Motus GI's share price to reach $7.67 in the next year. This suggests a possible upside of 253.3% from the stock's current price. View Analyst Price Targets for Motus GI.

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Motus GI in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Motus GI.

Press coverage about MOTS stock has trended somewhat positive recently, InfoTrie Sentiment reports. InfoTrie scores the sentiment of press coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Motus GI earned a media sentiment score of 1.8 on InfoTrie's scale. They also gave news stories about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the near term. View News Stories for Motus GI.

Based on aggregate information from My MarketBeat watchlists, some companies that other Motus GI investors own include Canopy Growth (CGC), Advanced Micro Devices (AMD), NVIDIA (NVDA), Alibaba Group (BABA), Sorrento Therapeutics (SRNE), Zynerba Pharmaceuticals (ZYNE), Verizon Communications (VZ), Corbus Pharmaceuticals (CRBP), Heron Therapeutics (HRTX) and Netflix (NFLX).

(MOTS) raised $21 million in an initial public offering on Wednesday, February 14th 2018. The company issued 3,500,000 shares at a price of $5.00-$7.00 per share. Piper Jaffray served as the underwriter for the IPO and Oppenheimer & Co. was co-manager.

Motus GI's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Magnetar Financial LLC (0.72%) and Eaton Vance Management (0.10%). Company insiders that own Motus GI stock include Andrew Lawrence Taylor, David P Hochman, Gary E Jacobs, Larry N Feinberg, Life Sciences Maste Perceptive, Mark Pomeranz and Timothy P Moran. View Institutional Ownership Trends for Motus GI.

MOTS stock was sold by a variety of institutional investors in the last quarter, including Magnetar Financial LLC and Eaton Vance Management. View Insider Buying and Selling for Motus GI.

Shares of MOTS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of MOTS stock can currently be purchased for approximately $2.17.